✦ LIBER ✦

E2F1andKIAA0191expression predicts breast cancer patient survival

✍ Scribed by Robin M Hallett; John A Hassell

Book ID: 115025189
Publisher: BioMed Central
Year: 2011
Tongue: English
Weight: 706 KB
Volume: 4
Category: Article
ISSN: 1756-0500
DOI: 10.1186/1756-0500-4-95

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

E2F1 Expression Predicts Outcome in Kore

E2F1 Expression Predicts Outcome in Korean Women Who Undergo Surgery for Breast Carcinoma

✍ Mi Jung Kwon; Eun Sook Nam; Seong Jin Cho; Hye Rim Park; Hyung Sik Shin; Jun Ho 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 332 KB

E2F1 Expression is Related with the Poor

E2F1 Expression is Related with the Poor Survival of Lymph Node-positive Breast Cancer Patients Treated with Fluorouracil, Doxorubicin and Cyclophosphamide

✍ Sehwan Han; Kyeongmee Park; Byung-Noe Bae; Ki Hwan Kim; Hong-Joo Kim; Young-Duck 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 126 KB

Securin predicts aneuploidy and survival

Securin predicts aneuploidy and survival in breast cancer

✍ Henna Karra; Reino Pitkänen; Marjukka Nykänen; Kati Talvinen; Teijo Kuopio; Mirv 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 516 KB

Measure of bone metastases predicts brea

Measure of bone metastases predicts breast cancer survival

📂 Article 📅 2011 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 52 KB

Vimentin DNA methylation predicts surviv

Vimentin DNA methylation predicts survival in breast cancer

✍ Jacob Ulirsch, Cheng Fan, George Knafl, Ming Jing Wu, Brett Coleman, Charles M. 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 868 KB

Nuclear karyopherin α2 expression predic

Nuclear karyopherin α2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity

✍ Oleg Gluz; Peter Wild; Robert Meiler; Raihana Diallo-Danebrock; Evelyn Ting; Svj 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 253 KB 👁 1 views

## Abstract Intensive lymph node involvement indicates poor prognosis in breast cancer patients. The significance of other molecular prognostic factors in this subgroup is unclear. Karyopherin α2 (KPNA2) has been reported as an important factor of tumorgenesis and progression of breast cancer. The